C-section and systemic inflammation synergize to disrupt the neonatal gut microbiota and brain development in a model

Cécile Morin1, Flora Faure2, Julie Mollet3

  • 1Université Paris Cité, Inserm, NeuroDiderot, F-75019 Paris, France; Department of Obstetrics and Gynecology, AP-HP, Robert Debré Hospital, 75019 Paris, France.

PubMed

Insights

Cesarean sections combined with perinatal inflammation worsen brain development in preterm infants. This synergy impacts gut microbes, brain connectivity, and neurodevelopmental outcomes, highlighting critical risks for very preterm neonates.

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Neonatology

Background:

  • Infants born very preterm face high risks of neurodevelopmental disorders.
  • Perinatal systemic inflammation and C-sections are common in very preterm births.
  • Existing mouse models partially replicate preterm infant neurodevelopmental deficits.

Purpose of the Study:

  • To investigate the synergistic effects of C-section and perinatal systemic inflammation on brain development.
  • To characterize neuropathological, imaging, and behavioral outcomes in a novel mouse model.

Main Methods:

  • Developed a mouse model using intraperitoneal IL-1β injections (postnatal days 1-5) to mimic perinatal inflammation.
  • Compared outcomes between C-section and vaginal delivery groups, with and without IL-1β treatment.
  • Assessed gut microbial diversity, circulating peptidoglycans, microglia/macrophage reactivity, myelination, and brain functional connectivity.

Main Results:

  • C-sections exacerbated IL-1β-induced reductions in gut microbial diversity and increased circulating peptidoglycans.
  • Synergistic effects led to abnormal microglia/macrophage reactivity and impaired myelination.
  • Combined C-section and inflammation significantly reduced brain functional connectivity.

Conclusions:

  • C-section delivery synergizes with neonatal systemic inflammation to cause severe brain maldevelopment and dysfunction.
  • These findings are relevant to very preterm infants at high risk for neurodevelopmental disorders.
  • The mouse model effectively replicates key deficits observed in preterm neonates.